SIRION Biotech is committed to improving clinical use of viral vectors, ultimately for the benefit of patients. The spirit of quality and awareness of the immediate impact of everyone’s work on clinical research and therapy performance is communicated through our employees. We share our values by word and through action, like the royalty-free access program to SIRION’s LentiBOOST® technology to research hospitals.
SIRION Biotech is very international. Our Founder and CEO, Dr. Christian Thirion, is French, and we have staff at our Munich HQ from Germany, Australia, Portugal, Ukraine, France, Japan, Canada, and Brasil. And staff in our US and French sites are from France, Belgium, Mexico, Lebanon, Brasil, Taiwan, Germany, and USA. Transparency, acting against discrimination, and performance-driven excellence also translates into an exceptionally high percentage of women at all levels of the company, particularly in leadership positions.
Please note: We are currently unable to accept applications for Apprenticeships or Bachelors and Masters degree projects.
SIRION Biotech is currently seeking:
Technischen Assistenten/ Research Assistenten (m/w/d), Qualitätskontrolle
Business Development & Licensing Manager (m/f/d) – part time
You will strengthen our Business Development & Licensing team. This team ensures that the company's growing technology portfolio in cell and gene therapy is increasingly applied in clinical developments and that these partnerships are contractually secured. Furthermore, it promotes own technology partnerships in the preclinical environment, always with a view to potential clinical applications. Contractual partners are international academic institutions and industrial partners, both of which serve the company as collaboration and licensing partners.
SIRION Biotech licences its LentiBOOST® transduction technology to Cellectis